Q2 2017 Posts Consistent Marks as VCs Continue to Place Larger Bets NYC Seed Deal Report for Q2 is out. Biggest trends for the quarter were:
Equity podcast: 500 Startups scandals, disappointing IPOs, and the end of JawboneHello and welcome back to Equity, TechCrunch’s venture capital podcast, where we dig into the hype, the dollars, and, recently, the down exits. This week was a fun one. Matthew Lynley is out on vacation, so TechCrunch’s own Megan Rose Dickey (the current host of Bullish and general badass) joined Katie Roof and myself — Alex Wilhelm — to dive into the news of the week. [ Tech Crunch ] Where Felix Capital Is Looking for OpportunitiesFrederic Court, Felix Capital Partners founder and managing partner, discusses the venture firm's investment strategy with Bloomberg's Caroline Hyde on "Bloomberg Technology." [ Bloomberg ] Inside Station F, the startup megacampus that just opened in ParisStation F is the world’s biggest startup campus. Thousands of entrepreneurs are currently moving into the new building here in Paris. But if you’re still wondering what it actually looks like, we visited Station F and interviewed the two persons behind it — Roxanne Varza and Xavier Niel. Station F is a massive building that has been completely renovated and now features thousands of desks, dozens of conference rooms, VC firms, a stage and more. It’s the size of the Eiffel Tower laying down, and it’s quite impressive in person. Station F has been years in the making. French billionaire Xavier Niel spent hundreds of millions of euros to purchase and transform the building into a sort of central hub for the French tech ecosystem with Roxanne Varza at the helm. A visual recap of global PE activity in 2Q 2017 [datagraphic]Venture capital fund NRV seeks promising investments in VirginiaIn June, NRV finished assembling a $33 million investment fund, called its Early-Stage Growth Fund, with money raised from 83 investors across Virginia. Billionaires dream of immortality. The rest of us worry about healthcareLast week, as the Senate was still trying to deny healthcare to 22 million fellow Americans, a friend asked me whether I would choose to live forever if I could. We were discussing Silicon Valley billionaires and their investments in new biotechnologies that they hope will enable them to do what no human has ever done: cheat death. The technology includes some dubious treatments, such as being pumped with the blood of much younger people. [ The Guardian ] |